# BioMarin

Delivery platforms — Vector engineering.

Source: https://en.bioecon.ru/companies/biomarin/
Updated: 2026-07-02

- Country: United States

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | $3.7 billion in debt financing for the Amicus Therapeutics acquisition, with $850 million in senior unsecured notes issued in Feb 2026 (2025-12-31) | https://www.sec.gov/Archives/edgar/data/1048477/000130817926000313/bmrn015087_ars.pdf |
| Capacity | 10,000 doses per year combined for valoctocogene roxaparvovec and BMN 307 (2020-09-24) | https://www.biomarin.com/news/press-releases/biomarin-announces-6-presentations-at-american-society-of-gene-and-cell-therapy-asgct-virtual-2021-annual-meeting/, https://www.biomarin.com/news/press-releases/biomarin-pioneer-in-phenylketonuria-to-begin-clinical-trial-with-bmn-307-gene-therapy/, https://www.prnewswire.com/news-releases/biomarin-pioneer-in-phenylketonuria-pku-and-gene-therapy-doses-first-participant-in-global-phearless-phase-12-study-of-bmn-307-gene-therapy-301137556.html |
| Certification | ISO 14001 and ISO 45001 at both manufacturing sites (2024-01-19) | https://www.biomarin.com/science/manufacturing/ |
| Certification | cGMP certified by the EMA for the Novato, California vector production facility (2020-06-30) | https://www.prnewswire.com/news-releases/biomarin-pioneer-in-phenylketonuria-pku-and-gene-therapy-doses-first-participant-in-global-phearless-phase-12-study-of-bmn-307-gene-therapy-301137556.html |
| Revenue | $3.221 billion for the full year 2025 (2025-12-31) | https://investors.biomarin.com/news/news-details/2026/BioMarin-Reports-Fourth-Quarter-and-Full-year-2025-Financial-and-Operating-Results/default.aspx, https://www.sec.gov/Archives/edgar/data/1048477/000130817926000313/bmrn015087_ars.pdf |
| Production site | Novato, California, USA | https://www.biomarin.com/contact-us/locations/, https://www.biomarin.com/science/manufacturing/ |
| Production site | Shanbally, County Cork, Ireland | https://www.biomarin.com/contact-us/locations/, https://www.biomarin.com/science/manufacturing/ |

Independent sources: prnewswire.com, sec.gov